COVID-19 Vaccine Research
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that makes coronavirus virus 2019 (COVID-19), has affected an expected 4,800,000 individuals worldwide. This week, development…
Coronavirus
COVID-19: Patients Improvements
Systemic anticoagulation may be correlated with enhanced outcomes among COVID-19 patients, according to an analysis letter published May 6 in the Journal of the American…
Coronavirus Antibodies Test
Some have proposed that identifying antibodies to SARS-CoV-2 (coronavirus antibodies) against coronavirus become the basis of “security passports” that allow people to return to work…
Home Test For COVID-19 Approved
The agency gave emergency allowance for a home test for COVID-19 that allows a customer to take a nasal unit at home and send it…
Mandatory Coronavirus Testing in South Africa
South Africa converted into the first African country to work out a large nationwide coronavirus testing plan to track and monitor the number of the…
COVID-19 Vaccine Development
A tuned and collaborative program to coronavirus infection 2019 (COVID-19) vaccine research and development (R&D) is highly required for a prosperous consequence, according to a…
COVID-19 Revealed by Biosensors
A team of investigators from Empa, ETH Zurich, and Zurich University Hospital has succeeded in developing a novel sensor that got COVID-19 revealed. In the…
COVID-19 Drive-Thru Testing
Although the grown-ups between 18 and 24 years of age are frequently using mass retailers with a drugstore, adults aged 65 years and over are…
Rare Diseases Community And Coronavirus
For the billions of residents living with a rare diseases, the new coronavirus infection COVID-19 sponsors trials, from probably reduced access to required medical care…
Abbott ID NOW Point-of-Care Test vs. COVID-19
Nowadays, the U.S. Food and Drug Administration is alerting the public to further data that recommends possible incorrect effects from using the Abbott ID NOW…